• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PDN

PALADIN ENERGY LTD - Charts / Financials

1.69% ! $6.41
Market Cap $2.557B  !
Metals & Mining Industrial Metals & Minerals
Add to My Watchlist

Paladin Energy Ltd is an Australia-based independent uranium producer with a 75%... Paladin Energy Ltd is an Australia-based independent uranium producer with a 75% ownership in the Langer Heinrich Mine (LHM) located in Namibia. The Company also owns a portfolio of uranium exploration and development assets in Canada and Australia. Its segments include Exploration, Namibia and Australia. The LHM is located in central western Namibia approximately 80 kilometers (km) east of Swakopmund and 85 km northeast of the Walvis Bay major deepwater harbor. Its Patterson Lake South (PLS) Project hosts the Triple R deposit, a large, high-grade and near-surface uranium deposit. The property comprises over 17 contiguous claims totaling 31,039 hectares. Its exploration projects include West Cluff, Larocque, Seahawk, Merlin, Corsair, Typhoon, Michelin, Manyingee and Mount Isa. The Company, through its subsidiary Aurora Energy Ltd, holds a 100% interest in over 98,320 hectares of mineral exploration licenses. These are located within the Central Mineral Belt of Labrador, Canada.More

refresh Created with Sketch. REFRESH
Last update - 15.59pm 15/05/2025 (20 minute delay) ?
Day
Open $6.46   Day High $6.63   Day Low $6.41
Daily Volume 3258722
Bids   Sellers
Number Price Volume   Number Price Volume
1 $6.41 45729   2 $6.45 18561

Directors & Senior Management

Mr. Ian Frank Purdy Chief Executive Officer
Ms. Anna Catherine Sudlow Chief Financial Officer
Mr. Paul Hemburrow Chief Operating Officer
Ms. Danielle Lazarov Chief People and Corporate Affairs Officer
Mr. Jeremy Ryan General Counsel, Company Secretary
Mr. Alex Rybak Chief Commercial Officer
Mr. Cliff Lawrenson Non-Executive Independent Chairman of the Board
Mrs. Lesley Adams Non-Executive Independent Director
Dr. Jonathan Hronsky Non-Executive Independent Director
Mr. Peter Winters Main Non-Executive Independent Director
Mr. Peter James Watson Non-Executive Independent Director

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$6.41 		Change
-0.110(1.69%) 		Mkt cap ! $2.557B
Open High Low Value Volume
$6.46 $6.63 $6.41 $21.11M 3.258M

Buyers (Bids)

No. Vol. Price($)
1 45729 $6.41
 

Sellers (Offers)

Price($) Vol. No.
$6.45 18561 2
View Market Depth
Last trade - 16.10pm 15/05/2025 (20 minute delay) ?
Last
$6.47 		  Change
-0.110 ( 1.61 %)
Open High Low Volume
$6.47 $6.63 $6.42 499080
Last updated 15.59pm 15/05/2025 ?

Top Stories

Metgasco (ASX:MEL) kicks off Entitlement Offer to accelerate gas production and cashflow

Metgasco (ASX:MEL) is conducting a partially underwritten shareholder entitlement offer to raise up to $750,000 at 0.2 cents per share. This is a 33% discount to the current 0.3 cents share price, 1 new share for every 3.89 existing shares (Record Date: 14 May 2025).Managing Director Ken Aitken j...
‘Spectacular results’: Odyssey Gold (ASX:ODY) prepares for Au production An airborne survey electromagnetic survey has identified @32’ new promising exploration targets within Odyssey Gold @s (ASX:ODY) Tuckanarra project.Tuckanarra, near Meekatharra in WA, has been of interest to miners over many decades @ there are four existing open pits there, along...
Gold, niobium, helium and more: Which explorers found what on Thursday? It can be hard to keep an eye on all of the ASX explorers. Here's what caught eyes on Thursday when it comes to junior...
Record gold prices, overlooked acreage & a looming maiden JORC. How this stock could become a household name As the gold metal has cooled from the ~US$3,500/oz mark in recent weeks, the commodity's performance through CY2024, and year...
Could this ASX stock become the next Pfizer? A look at AFT Pharmaceuticals With biotech stocks broadly having a strong run in 2025, and with more of the year ahead, investors are still looking for stocks...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.